These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
Jun 13, 2017
Special Meeting of OncoGenex Stockholders to Vote on Proposed Merger Scheduled for August 1, 2017
Mar 8, 2017
Professor Nancy Rigotti, MD, will chair a symposium entitled "Cytisine Update: Moving Research Forward Toward a Globally Affordable Tobacco Cessation Medication"
Mar 1, 2017
Ongoing IND-enabling Non-clinical Program to Support the Use of Cytisine in Smoking Cessation
Jan 5, 2017
Proposed Merger Will Create Clinical-Stage, Biopharmaceutical Company Focused on the Development and Commercialization of Cytisine for Smoking Cessation